Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1355662rdf:typepubmed:Citationlld:pubmed
pubmed-article:1355662lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0034804lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0080055lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:1355662lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:1355662pubmed:issue3lld:pubmed
pubmed-article:1355662pubmed:dateCreated1992-10-15lld:pubmed
pubmed-article:1355662pubmed:abstractTextThe expression of p53 protein, oestrogen receptor protein, epidermal growth factor receptor (EGFR) and overexpression of the c-erbB-2 oncoprotein was examined in a series of 149 primary symptomatic breast carcinomas. Expression of p53 was present in 62 of 146 cases (42.5%) of the invasive carcinoma and one of three cases (33.3%) of ductal carcinoma in situ (DCIS) examined. Statistical associations of tumour oestrogen receptor positivity and lack of p53 protein expression, chi 2 = 19.78 (d.f. = 1), P less than 0.001, positive tumour p53 status and poor tumour grade; chi 2 = 14.1 (d.f. = 2), P less than 0.001, EGFR expression chi 2 = 7.07, (d.f. = 1), P less than 0.01 and tumour c-erbB-2 protein overexpression; chi 2 = 4.61 (d.f. = 1), P = 0.032 were identified. Expression of p53 is rare in invasive lobular carcinoma of classical type (8.3% of cases examined) in contrast to other common types of mammary carcinoma. Non-significant trends of p53 protein expression and increased regional tumour recurrence; chi 2 = 3.20 (d.f. = 1), P = 0.074 and also poorer patient survival; chi 2 = 3.76 (d.f. = 1), P = 0.053 were identified. p53 protein expression is a common event in human breast cancer and is present in both DCIS and invasive mammary carcinoma. Abnormal expression of p53 protein is a feature of both in situ and invasive breast carcinoma, implying that the abnormal p53 protein expression may be implicated in the early stages of mammary carcinoma progression.lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:languageenglld:pubmed
pubmed-article:1355662pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:citationSubsetIMlld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1355662pubmed:statusMEDLINElld:pubmed
pubmed-article:1355662pubmed:monthSeplld:pubmed
pubmed-article:1355662pubmed:issn0007-0920lld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:BellJ AJAlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:BlameyR WRWlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:ElstonC WCWlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:NicholsonR...lld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:EllisI OIOlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:GaleaMMlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:PollerD NDNlld:pubmed
pubmed-article:1355662pubmed:authorpubmed-author:HutchingsC...lld:pubmed
pubmed-article:1355662pubmed:issnTypePrintlld:pubmed
pubmed-article:1355662pubmed:volume66lld:pubmed
pubmed-article:1355662pubmed:ownerNLMlld:pubmed
pubmed-article:1355662pubmed:authorsCompleteYlld:pubmed
pubmed-article:1355662pubmed:pagination583-8lld:pubmed
pubmed-article:1355662pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:meshHeadingpubmed-meshheading:1355662-...lld:pubmed
pubmed-article:1355662pubmed:year1992lld:pubmed
pubmed-article:1355662pubmed:articleTitlep53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.lld:pubmed
pubmed-article:1355662pubmed:affiliationDepartment of Histopathology, City Hospital, Nottingham, UK.lld:pubmed
pubmed-article:1355662pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1355662pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed